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Abstract: 
 MicroRNAs are small non-coding RNAs that regulate gene expression post-
transcriptionally (Bartel, 2009). Several different microRNAs have been implicated in regulatory 
pathways of skin morphogenesis, stem cells, skin cancer, and other skin diseases. A subset of 
microRNAs have been found to be differentially expressed in distinct skin lineages, namely 
epidermis and hair follicle (Yi et al., 2006).  Characterization of the spatial and temporal 
expression patterns of these microRNAs can provide a basis to investigate their functions during 
development as well as in skin diseases including skin cancer.  During my thesis study, I 
employed in situ hybridization to characterize the differential expression of four discrete 
microRNAs: miR-203, miR-143, miR-125b, and miR-205 in mammalian skin.  My results 
demonstrated that miR-203 is highly expressed in differentiating skin lineages, miR-143 is 
enriched in the transient amplifying cells in hair follicle matrix, miR-125b and miR-205 are 
enriched in skin stem cells. I also cloned three regions upstream of miR-205 and analyzed their 
promoter activity in cultured keratinocytes. Together, my study shows that miRNAs are 
differentially expressed in distinct skin lineages and provides a basis to analyze their functions in 
the future.  
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Chapter 1: Background 
Section 1: Importance of MicroRNA and Mammalian Skin Models 
 As more information about microRNAs is uncovered, their role in cellular processes 
becomes more significant. There are 222 identified microRNA in humans but it is estimated that 
there are at least 800 total human microRNAs (Bentwich et al., 2005).  MicroRNAs play key 
roles in the regulation of many diverse physiological events including: stem cell differentiation, 
haematopoiesis, insulin secretion, cholesterol metabolism, and immune responses (Williams, 
2008).  The involvement of microRNAs in cancer is also an expanding field of research.  
MicroRNA expression levels can be used as a diagnostic tool for cancer patients as an aid in 
determining their prognosis (Lee and Dutta, 2009). MicroRNAs are known to regulate stem cell 
differentiation in mammalian skin.  They are involved in embryonic development, hair follicle 
morphogenesis, and the regulation of bulge stem cells. In order to understand the development of 
hair follicles and regulation of skin stem cells, it is vital to understand microRNA’s role in the 
skin cells.  
 The skin is a barrier between the external environment and the body and as a result is 
exposed to many toxins and different environments.  In order to protect the body from harmful 
exposures and injury, the skin must have the ability to regenerate quickly. The skin is an ideal 
organ to study stem cell differentiation because of its regenerative properties and the ease of 
tissue acquisition.  
  
Section 2: Importance of Stem Cell Regulation 
 Stem cells are undifferentiated cells with the capability to self-renew and differentiate to 
become different cell types. There are four categories of stem cells: totipotent, pluripotent, 
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multipotent, and unipotent.  Each type of stem cell has the capability of producing other cells; the 
distinction between each type is the amount and variety of cells they can renew.  Totipotent cells 
are able to form all cells of an embryo including the somatic and germline cells of the zygote, as 
well as the surrounding placenta.  Totipotent cells can differentiate into pluripotent cells; these 
cells are able to differentiate into all three germ layers of an embryo: endoderm, mesoderm, and 
ectoderm.  Once tissues become more specialized, multipotent cells become the stem cell 
population.  Multipotent stem cells, the most abundant stem cells in adults, are responsible for 
the differentiation and creation of cell lineages.  These stem cells have the ability to re-new and 
regenerate multiple cell lineages in a given system.  For example, the skin has a very high 
turnover rate and thus needs to repopulate the epithelial cells, in addition to maintaining other 
cell types such as the sebaceous gland cells.  If only one type of cell needs to be regenerated, 
unipotent stem cells can repopulate those specific types of cells.  
 Stem cells are fascinating because their ability to regenerate tissue and organs holds 
promise in the treatment of diseases.  Although stem cells are unique for their ability to 
regenerate, stem cells also play an important role in forging the front of personalized medicine 
and drug screening. Stem cells have interesting regulation mechanisms that can help scientists 
understand cellular regulation, disease pathways, and tissue regeneration. The regulatory 
mechanisms and manipulation of stem cells can be applied in human biology and medicine, 
particularly cancer and the regeneration of damaged tissues. Knowing what turns a stem cell “on 
and off” will lead to greater insight as to how stem cells differentiate or stay in an 
undifferentiated state.   
There are many hypotheses describing the regulation of stem cells. One hypothesis is that 
the environment surrounding the stem cell population produces signals that keep the cells in an 
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undifferentiated state until they leave that environment.  This environment is often referred to as 
a stem cell niche.  Another current hypothesis suggests that stem cells are inherently different 
and already have a cell autonomous fate.  In this model differentiation signals come from within 
the cell, possibly signaled from an event outside the cell or even an adjacent stem cell 
(notch/delta signaling), that lead to that stem cell’s differentiation.  
 In reality, the regulation of stem cells is a dynamic process that includes several different 
regulatory strategies.  Over the past decade microRNAs have emerged as a central regulatory 
mechanism in the gene expression of many different cell types and show promise in broadening 
our understanding of how stem cells become committed to a specific cell lineage. 
  
Section 3: MicroRNA Biogenesis and Function 
 The Central Dogma of Biology describes the flow of information from DNA to RNA to 
protein.  Deoxyribonucleic acid (DNA) is transcribed into ribonucleic acid (RNA), which is then 
translated into protein.   Figure 1.1 illustrates how microRNA affects the central dogma. 
Figure 1.1 
 
 
 
 
 
 
DNA is the template for messenger RNA (mRNA), which is transcribed within the nucleus.  Once the RNA 
is transcribed, it is processed and transported from the nucleus to the cytoplasm.  The messenger RNA 
 is translated into protein by ribosomes that are located in the cytoplasm and on the endoplasmic reticulum. 
Central Dogma: 
 
 Transcription   Translation 
 
DNA                      mRNA       Protein 
 
 
 
      MicroRNA 
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MicroRNAs are regulatory molecules that function by inhibiting the translation of mRNA transcripts. They can act 
by targeting the mRNA for degradation or by inhibiting initiation factors needed for the start of translation. Thus 
microRNAs are able to regulate the number of transcripts that are available for translation and ultimately the protein 
concentration in cells.  This protein regulation can affect a variety of physiological events. 
 MicroRNAs are non-coding RNAs that are 20-23 nucleotide (nt) sequences. Since they are 
non-coding transcripts, they are often found in introns and intergenic regions of DNA 
(Bostjancic and Glavac, 2008).  Intergenic regions were once thought to be “junk” DNA because 
they did not produce transcripts for coding proteins.  It was also thought that non-coding regions 
of DNA served no functional purpose in cells. These views on the non-coding regions of DNA 
are no longer thought to be valid.  It is widely accepted that previously overlooked DNA regions 
(including those that encode microRNAs) actually serve a vital role in regulating transcript and 
protein levels.   
 MicroRNAs are transcribed from intergenic and intron regions by RNA Polymerase II 
(RNA Pol II) (Figure 1.2).  The resulting transcript is a primary microRNA, pri-miRNA.  
 The pri-miRNA forms a hairpin structure with two stands of 30 nucleotides (nt) base 
paired to each other with a loop on the top. It is processed A microprocessor complex composed 
of Drosha and DiGeorge syndrome Critical Region Gene 8 (DGCR8) catalyzes this cleavage 
event. Together Drosha/DGCR8 are responsible for the cleavage the pri-miRNA to precursor 
microRNA or pre-miRNA.  
Once the pre-miRNA is created in the nucleus, it is exported to the cytoplasm via 
exportin5, a member of the nuclear transport receptor family, previously known to transport 
tRNA to the cytoplasm (Kim et al., 2009). After the pre-miRNA has been successfully 
transported out of the nucleus, full maturation can take place.  
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In the cytoplasm, Dicer, a highly conserved enzyme in eukaryotes, binds and cuts the pre-
miRNA at the top of the hairpin loop resulting in a duplex of RNA about 22 nt in length (Kim et 
al., 2009).  Argonaute (Ago) proteins then bind to the newly cut RNA; however, they only bind 
one strand, which becomes the guide strand. The guide strand will be the mature microRNA used 
to target endogenous mRNAs.  The other 22 nt strand, known as the passenger stand, will be 
degraded by specific mechanisms that have not been fully elucidated (Kim et al., 2009).  
Once Ago has made its selection as to which strand will be utilized as the mature 
miRNA, Dicer binds to the Ago-RNA segment, thus forming an RNA-Induced Silencing 
Complex (RISC). Once the RISC complex is fully assembled, the miRNA is able to find and 
bind to its target mRNA, thereby preventing the mRNA from being translated. If the miRNA 
targeting is potent and efficient, the change in gene expression can alter the fate of the cell. 
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Figure 1.2 (Kim et al., 2009) 
 
 
!
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When encapsulated within RISC, microRNAs function by targeting and silencing mRNA 
transcripts.  A typical target region for miRNA is the 3’ untranslated region (UTR) of the 
transcript. When mRNAs are transcribed, not all of the transcript will be translated into a protein.  
The regions that are not translated are thus referred to as UTR’s.  MicroRNAs are able to bind 
specifically to these regions to inhibit translation or promote RNA degradation. MicroRNAs also 
have the ability to target multiple mRNA transcripts, leading to the coordinated alteration of 
gene expression that can change the fate and function of cells.  
If the microRNA binds perfectly to the mRNA target, the transcript will be degraded 
(Valencia-Sanchez et al., 2006). However, if the binding is imperfect, the mRNA transcript will 
be translationally repressed.  RISC is able to inhibit initiation factors preventing translation from 
occurring (Valencia-Sanchez et al., 2006).  Regardless of the accuracy of RNA binding, 
microRNAs will decrease gene expression by either degrading specific mRNA transcripts or 
inhibiting the translation of those target mRNAs.   Further detail of mRNA degradation and 
translational inhibition can be found the Appendix, Section 4.  
 
Section 4: Skin Cell Lineages 
 The skin serves as a barrier to protect the body from the outside environment. In order to 
maintain and re-populate the stratified epithelium, skin stem cells must have the ability to self-
renew and differentiate into different layers of the skin. The skin has many layers of cells 
composed of both the interfollicluar epithelium (skin between hair follicles) and the hair follicle. 
Understanding how micro RNAs regulate the development of stem cells into these different cell 
types with specific functions will aid the research of stem cells in general.  The first step in 
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determining how microRNAs function and regulate stem cell differentiation is determining in 
which epithelial lineage those microRNAs are expressed. 
Skin cell lineages are determined in embryogenesis and more fully developed a few 
weeks after birth.  The general morphology of hair follicles during embryogenesis is known, but 
their regulation by microRNA is undetermined. Figure 2 illustrates the developmental stages of 
hair follicles and the interfollicluar epidermis.  
 
Figure 1.3. (Yi and Fuchs., 2010) 
 
 
 Figure 2 shows the development of the epidermis and hair follicle.  Starting around Embryonic day 13 
(E13), single layers of epithelial cells compose the basal layer (BL). This layer is marked by keratin 5 and 14.  As a 
few days pass, the BL forms two different lineages: epidermis and hair follicle.  The basal layer asymmetrically 
divides producing multiple layers of differentiated cells call the suprabasal layer (SB).  Hair follicle development 
starts as the basal layer invaginates into the dermis.  As the development progresses from the placode to mature hair 
follicle, several lineages of cells are created: bulge, outer root sheath (ORS), inner root sheath (IRS), pre-cortex fork, 
sebaceous gland (SG), and matrix cells.   
 During development, cells are assigned to different jobs.  The jobs help carry out the 
functions of the skin and hair follicle. Terminally differentiated cells have been assigned a job 
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that they will carry out until they die.  These cells do not replicate and therefore have no self-
renewal capacity, but their job still needs to be done once these cells are gone.  Undifferentiated 
cells are thus needed to regenerate the terminally differentiated cells. Figure 3 shows the cell 
lineages and their specified differentiated states.  
 
Figure 1.4. 
 
Figure 3 shows the different cell lineages and their relative state of differentiation.  The blue cells are 
undifferentiated; they have more stem cell like properties.  The bulge region and the basal layer are considered to be 
the stem cells responsible for re–constituting the interfollicluar epidermis and the hair follicle.  The orange cells are 
more terminally differentiated cells.  These lineages do not have the capacity to self-renew.  The sebaceous gland is 
composed of both stem cells and terminally differentiated cells. The matrix cells are transit-amplifying cells.  These 
cells are unique because they are rapidly dividing and differentiating simultaneously.  
 
Basal 
Suprabasal 
Sebaceous Gland 
Matrix cells 
Dermal Papilla 
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Outer Root Sheath Bulge 
Undifferentiated 
Differentiated 
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 As cells in the epidermis travel closer to the environment and away from the basal layer 
they become more terminally differentiated.  The differentiated cells in the epidermis are referred 
to as the suprabasal layer.  The suprabasal layer includes the spinous and granular layers.  The 
Stratum Corneum is composed of dead epithelial cells and therefore is not considered part of the 
suprabasal layer. Figure 1.5 clarifies the nomenclature.  
Figure 1.5.  
 
Illustration showing the orientation of the different cell layers in the epidermis. 
 Epithelial cells provide structure and protection for the body.  Keratins are proteins found 
in epithelial cells that help provide structure and rigidity by creating scaffolds within the cells. 
Keratins are a family of proteins that are composed of many specific types of keratin.  The 
different layers in the skin express different members of the keratin family. Basal cells express 
Keratin 5 and 14 (K5, K14), whereas the suprabasal layer cells expresses K1 and K10.  These 
differences in keratin expression help researchers label and mark different cell types.   As the 
cells differentiate and move toward the surface of the skin the keratins become longer and 
stronger eventually becoming fully keratinized in the stratum corneum layer. 
 
 
 
 
Basal Layer  
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Granular Layer 
Stratum Corneum 
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Section 5: Hair Follicle Cycling 
 Mammals need to re-grow hair follicles frequently to compensate for wear and tear as 
well as seasonal changes. This consistent regeneration of hair follicles provides an excellent 
model for examining the regulation of stem cell differentiation. 
 Hair follicle cycles in most mammals consist of three main stages: anagen, catagen, and 
telogen. Hair growth takes place in anagen, while catagen is referred to as the disintegration of 
the hair follicle.  Telogen is the rest period between catagen and anagen. Mice are a good model 
system for examining hair follicle regeneration because most mice undergo these three hair 
cycles. Several variables can affect the timing between stages in mice: genetic backgrounds, 
gender, nutrition, and environmental factors (Muller-Rover et al., 2001).  Environmental factors 
include time of year, temperature, and light periods. Female mice are known to have longer 
telogen cycles than males.  
 Hair follicle development begins in murine embryogenesis and continues until the first 
catagen stage around postnatal day 16 (P16).  At this point the hair follicle cycle starts and 
continues throughout the animal’s life.  Telogen soon follows catagen at P19, which is then 
followed by the first cycle of anagen, roughly from P28 until P42 (Figure 6).  The depth of the 
follicle, position of Dermal Papilla (DP) cells, and the complexity of the follicle structure (Figure 
7) characterize the stages of each cycle.  For more details regarding hair follicle cycles see the 
Appendix, Section 4.  
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Figure 1.6 (Muller-Rover et al., 2001) Figure 1.7 (Muller-Rover et al., 2001) 
    
Figure 6 shows the progression of a full hair cycle starting from telogen through catagen.   
Figure 7 shows the time frame for hair follicle cycling in increments of weeks.  
 
Section 6: MicroRNAs in the Skin  
 MicroRNAs are found in mammalian skin tissue and are thought to play a role in hair 
follicle morphogenesis. It is believed that a discrete set of microRNAs are essential for the 
development of the hair follicles (Yi et al., 2006). This was determined by investigating hair 
follicle development in mice skin in the absence of microRNA. A knock-out mouse, in which the 
gene is completely removed from the animal, was created deleting Dicer. When this gene was 
absent, it was lethal for the mice suggesting that microRNAs are essential for normal 
development. In order to discern if microRNAs were essential to the development of the 
epidermis and hair follicle, a conditional knock-out mouse was made.   
 Conditional murine knock-out mice are animals where the gene of interest (Dicer) can be 
inactivated under certain conditions. These mice are used for studying the function of a gene 
when conventional knock-outs are lethal to the animal.  For the purpose of discerning the role of 
microRNAs in hair follicle development, microRNAs were removed from skin cells, leaving all 
other cells functional.  The resulting phenotypes of conditional Dicer knock-outs were mild in 
that the mice appeared dehydrated and small with minimal fat.  However the life expectancy of 
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these mice was only four to six days after birth. Those phenotypes were not as crucial to 
understanding the role of microRNA as were the histological effects. A histological examination 
of the epithelial tissue of the conditional knock-out mice showed that even as the age of mice 
increased, visible “germ-like” cysts were still present in their skin cells.  Usually after birth the 
epithelial cells have minimal cyst formations and more hair follicles.  Hair germs were 
evaginated rather than invaginated.  Hair follicles that were present before the deletion of Dicer 
showed arrested growth.  Dicer deletion had obvious effects on hair follicles and their growth, 
but minimally affected the interfollicular epidermis (the areas surrounding hair follicles) (Yi et 
al., 2006).  Yi determined that a subset of microRNAs must be differentially expressed in 
developing mice.  Some of the most abundant microRNAs that were specific to skin were: miR-
203, miR-205, miR-143, and miR-125b (Yi et al., 2006).    
 
Section 7: Previous Knowledge and Published Data  
 If microRNAs can have differential expression patterns in the skin then they must have 
different functions.  The expression pattern of miR-203 has been well characterized (Yi et al., 
2008).  However, the expression patterns and functions of the microRNAs miR-143, miR125b, 
and miR-205 in the skin have not been determined.  The spatial and temporal expression of these 
microRNAs needs to be characterized in order to ascertain their function and role in hair follicle 
morphogenesis and stem cell regulation. It is helpful to look at the functions of microRNAs in 
other tissues because those functions might parallel that in the skin.   
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A. MiR-203: 
 MiR-203 is highly expressed in the suprabasal skin layer once differentiation begins in 
embryos 15.5 days after conception (Yi et al., 2008).  Figure 7 shows the abundant expression of 
miR-203 specifically in the suprabasal layer in embryonic skin and in postnatal skin.  
Figure 1.8 
 
 
 
Temporal induction of miR-203 as measured by cloning frequency. b, d, e, In situ hybridization reveals restriction 
of miR-203 to suprabasal, differentiating layers of skin. sb, suprabasal; bl, basal layer; epi, epidermis; der, dermis; 
sg, sebaceous gland; irs, inner root sheath; hf, hair follicle. Asterisks in e represent brown melanin pigment that is 
not a hybridization signal. In b, anti-4-integrin co-labelling is in green and miR-203 in situ pseudocoloured signal is 
in red. c, qRT–PCR of FACS-purified cells from E15.5 epidermis reveals 25-fold more miR-203 in suprabasal (SB) 
versus basal layer (BL) cells (*P < 0.002). Error bars (s.d.) are derived from three experiments with basal layer level 
set as 1. Scale bars are 30 m (Yi et al., 2008) 
 Interestingly, Yi and colleagues discovered that one of miR-203’s targets is P-63.  P-63 is 
a protein that can drive cell differentiation and is important in stem cell maintenance, especially 
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in stratified epithelial tissues (Yi et al., 2008).  MiR-203 is abundantly expressed in the skin and 
to date is not known to have important functions in other tissues.  
 B. MiR-143 
  MiR-143’s expression is uncharacterized in the skin.  However, in other research, 
miR-143 is expressed in tissues associated with smooth muscle (Cordes et al., 2009).   Smooth 
muscle is located in vessels (blood and lymph) and tract systems including: gastrointestinal, 
reproductive, and respiratory.  MiR-143 is as an important player in the maintenance of smooth 
muscle tissue and vascular homeostasis (Elia et al., 2009).  MiR-143 is down regulated in human 
tissues that have aortic aneurysms (Elia et al., 2009).  Thus, it is believed that a loss of miR-143 
contributes to structural modifications of the aorta because there is incomplete differentiation of 
vascular smooth muscle cells (Elia et al., 2009).   
 MiR-143 is also implicated to have a functional role in prostate cancer (Clape et al., 
2009).  This micro RNA is thought to act as a tumor suppressor by inhibiting the expression of 
an oncogene.  Human prostate cancer samples show down-regulation of miR-143 (Clape et al., 
2009).  
Adipose tissue is also affected by miR-143’s presence. MiR-143 is positively correlated 
with adipose differentiation (Takanabe et al., 2008) indicating that this microRNA plays a 
similar role in fat cells as it does in smooth muscle cells, it promotes differentiation.  When mice 
were fed a high fat diet, up-regulation of miR-143 was detected in the mesenteric fat (Takanabe 
et al., 2008).  This data suggests a correlation between the expression of miR-143 and obesity.   
 To date, there are no reports of miR -143 expression in mouse skin cells, during 
embryonic, neonatal, or postnatal skin development.  Microarray data from the Yi and colleagues 
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suggests miR-143 is expressed in matrix cells. However, this data needs to be supported by in 
situ hybridization to show the relative abundance and localization of miR-143 expression.  
 c. MiR-125b 
  The microRNA miR-125b acts to repress stem cell differentiation in skin cells (Zhang et 
al., 2011). Zhang et al, found miR-125b to be expressed in the upper outer root sheath, bulge, 
and basal cells.  All of these cell types are undifferentiated cells that need to be triggered to 
differentiate.  MiR-125b helps keep these cells in their undifferentiated state. 
Figure 1.9 (Zhang et al., 2011)  
 
 (C) miRNA-microarray results and RT-PCR verification of expression patterns of the miRs indicated. P6 
was used as the reference gene in RT-PCR. Error bars represent standard error. (D and E) miR-125b in situ 
hybridizations of WT P4 and P17 back skins. In situ signals (black) were developed by BM purple substrate: K5 
(green) in ORS and basal IFE. Scale bars represent 50 µm. 
 
 My results studying the expression of this microRNA were found before this publication.  
At the time of my studies, miR125b was a novel microRNA in the skin and other tissues.  
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D. MiR-205 
 MiR-205 is highly expressed in the skin, as shown by Yi and colleagues, but this 
microRNA has recently been found to play important roles in other tissues and cancer (Yi et al., 
2006). It has also been suggested that miR-205 functions in progenitor cell populations.  
 MiR-205 was found to be present in a population of stem cells isolated from the 
mammary gland (Greene et al.,2010).  These researchers found that miR-205 inhibited PTEN, a 
known tumor suppressor (Greene et al.,2010).  The inhibition of a PTEN suggests that miR-205 
encourages the cells to grow and divide, which are characteristic of stem cell populations. Mir-
205 is expressed in other cells including neuronal precursor cells (Dogini et al., 2008) including 
those involved in  olfactory neurogenesis (Choi et al., 2008).  
 Mir-205 is highly abundant in skin cells and functions in other tissues to promote stem 
cell characteristics suggesting that it may also play a role in skin stem cells.  In order to explore 
this idea, the localization and transcriptional regulation of miR-205 needs to be determined in 
both embryonic and adult skin cells.  
  
Section 8: Experimental Plan 
 MicroRNAs play different but vital roles in the progression of stem cells to terminally 
differentiated cells in the skin. I hypothesize that the microRNAs miR-203, miR-143, miR-125b, 
and miR-205 will be expressed in dissimilar skin and hair follicle cell lineages as a function of 
their differential role in the stem cells process.  
 One method to determine the expression pattern of microRNA is by in situ hybridization.  
This method allows researchers to characterize the location and relative abundance of 
microRNAs in cross-sections of tissue. Using this method I will compare the expression of the 
microRNAs miR-143, miR-125b, and miR-205 to the microRNA miR-203 (as a positive control) 
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in both embryonic and adult skin samples.  I will also explore the relative expression patterns for 
miR-143 and miR-125b in postnatal mice from days four and six (P4 and P6). I will characterize 
the expression of miR-143 and miR-205 in embryonic tissue.   The transcriptional regulation of 
miR-205 may be key to understanding the differentiation of skin stem cells.  MiR-205 is the 
second most abundant microRNA in the skin, and is potentially a regulating factor in skin stem 
cells. 
 Once the expression pattern for miR-205 is elucidated, I will examine how it is regulated 
in the specific cells in which it is expressed. I will investigate potential promoter regions that 
activate the transcription of miR-205 using luciferase assays.  I will assay several different DNA 
regions that are hypothesized to drive the expression of miR-205.  
 
Chapter 2: Methods and Materials 
Section 1: In Situ Hybridization 
 In situ hybridization (ISH) is a technique that is used to label DNA and RNA in tissues.  
ISH can be used to determine the spatial and temporal expression patterns of microRNA 
expression.  In my experiments, I will use this technique to show the localization and relative 
abundance of microRNA in skin sections.  There are two different methods of ISH: Nitro-blue-
tetrazolium with 5-bromo4-choloro-3 indolyphosphate (NBT/BCIP) and Fluorescent In Situ 
Hybridization (FISH). Below is an illustration highlighting the important steps in both in situ 
hybridization methods. For a more detailed explanation of this technique please refer to the 
appendix (Section 2).  
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Figure 2.1  
 
In order to study the skin, samples are taken from the backs of mice.  They are embedded into OCT and 
frozen.  Once they are frozen, sections are made by cutting the block of frozen tissue in a cross-sectional manner.  
Cut sections are transferred onto glass microscope slides and fixed with 4% paraformaldehyde (PFA).  This cross-
links proteins to each other preserving the tissue. 
Figure 2.2 
 
After the sections have been fixed, Proteinase K is added. Proteinase K degrades proteins in the cells to 
expose microRNA and permeabilizes the cells for the probe to have easier entry. Acetylation of the tissue decreases 
the background noise from non-specific hybridization.  Locked nucleic acid (LNA) probes (from Exiqon) labeled 
In Situ Hybridization 
Embedding 
 
Sect ion ing 
 
 
 
Cross- 
Sect ions 
S 
l 
i 
d 
e 
Fixation 
 
 
 
Morphology: 
“In Si tu” 
In Situ Hybridization 
Continued! 
S 
l 
i 
d 
e 
Fixation 
4%PFA 
 
 
 
Morp hology: 
In Situ 
Proteinase  K 
 
 
 
Incre ases 
Perme ability 
of cells and 
exposes 
mi cro RNA 
= mi RNA 
Ace tyla tion 
 
 
 
Decreases  
Background 
noise 
= mi RNA 
= mi RNA = Labeled probe 
St ringent  
Washes 
 
 
 
 = mi RNA = Labeled pro be 
Development & 
Amplification: 
1)N BT /BC IP 
2)F luore scent ISH  
Hybrid ization 
 24 
with Digoxigenin (DIG) are used as probes to hybridize to the microRNAs. The probes are labeled with 
Digoxigenin, which is recognized by the antibodies in this assay.  This is ideal for ISH detection.  
The synthetic nucleotide sequences of these probes have altered structural confirmations 
that increase the stability of dsRNA, which is critical for microRNA hybridization.  The LNA 
probes help stabilize the microRNA/probe duplex preserving and potentially amplifying genuine 
signals.  It is important to stabilize these duplexes when exploring microRNA expression 
patterns because some microRNAs are not as abundant and any degradation or instability in the 
probe could alter the hybridization signal.  
After the probes have been hybridized to the microRNA, either NBT/BCIP or 
Fluorescent ISH methods are used to amplify the microRNA signal.  
A. NBT/BCIP produces a “black and white picture”.  For NBT/BCIP, an alkaline 
phosphatase (AP) enzyme is attached to the antibody regcognizing the DIG label on the probe 
(Anti-DIG).  This enzyme converts the substrate into a dark precipitate.   The substrates for this 
reaction are: nitro-blue tetrazolium (NBT) and 5-bromo-4-chloro-3'-indolyphosphate (BCIP).  
After several hours, the dark precipitate is localized to the  target microRNA. Figure 2.2 shows 
the recognition and enzymatic reaction leading to the precipitation product.  
 
 
 
 
 
 
 
 
 25 
Figure 2.3 
 
 Once the probe is hybridized to the microRNA, an antibody conjugated with alkaline phosphatase (AP) 
recognizes and binds to the DIG label.  When the substrates are added, AP will catalyze the reaction and leave a 
dark precipitate where the microRNA is located.  
B. Fluorescent In Situ Hybridization (FISH) is similar to NBT/BCIP.  FISH differs in 
method because it uses an antibody that recognizes the DIG label on the probe but the antibody 
is conjugated with horse-radish peroxidase (POD) enzyme rather than alkaline phosphatase.  The 
substrate is Tryamide, which is converted into a fluoroform. (Specific details of this reaction can 
be found in the Appendix Section 5).  
Amplification of the fluorescent label only takes several minutes as opposed to several 
hours with NBT/BCIP.  After amplification, the sections can be co-stained and visualized using 
different light channels. In these experiments Beta 4 integrin is commonly used to label the 
lining of the basal layer and the nucleus of the cells is dyed with Hoechest, a fluorescent dye that 
Probe labeling NBT/ BCIP AP
Micro RNA
Probe with labeled  DIG
Anti DIG  AP (alkaline  phosphatase enzyme)   
Precipitation reaction creating visible signal
NBT/ BCIP  
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is incorporated into the DNA.  These co-stains are important because they provide context and 
the contrast necessary to detect the fluorescently labeled microRNA on a sub-cellular basis.   
Figure 2.4 
 
 After the DIG labeled probe has been hybridized to the microRNA, anti-DIG POD is added to the 
prepared tissue.  This antibody which is conjugated to a peroxidase enzyme recognizes the DIG label .  Before the 
Tyramide substrate is added, hydrogen peroxide is used to inactivate endogenous peroxidase activity. Amplification 
usually takes between 5-15 min.  
Confocal microscopy was used to detect the FISH labeled micro RNAs in the tissue 
samples.  Confocal microscopes can produce a three-dimensional image since they have three 
axes: X, Y, and Z, (Other microscopes have an X and Y axis which gives a two-dimensional 
picture of a slide). Confocal microscopy produces extremely high-resolution pictures showing 
sub-cellular localization of microRNA. (See the Appendix, Section 5 for a visual representation 
of confocal imaging). 
 In situ hybridizations were performed with both NBT/BCIP and FISH on embryonic, 
neonatal, and adult murine skin.  Sections varied in thickness but ranged between 10-14µm (See 
Appendix Section 5 for a more detailed description of embedding and sectioning).  
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Section 2: Real Time Quantitative Polymerase Chain Reaction (RT-qPCR) 
 Real Time Quantitative Polymerase Chain Reaction (RT-qPCR) is a way to quantify the 
relative amount of a specific amplified DNA sequence.  This method was used to identify and 
quantify various microRNA levels. RT-qPCR is based on the polymerase chain reaction (PCR) 
technique.  PCR is a technique that amplifies specific sequences of DNA. Primers are made that 
flank both the 5’ and 3’ ends of the DNA sequence of interest and direct the DNA polymerase to 
synthesize new complimentary strands of that target DNA sequence.  This synthesis reaction is 
repeated in a number of cycles that allows the target DNA to be amplified exponentially. 
Quantitative PCR uses the same technique as PCR, however the amount of the amplified 
DNA is measured by quantifying fluorescence readings.  Fluorescent dyes are added to the 
reaction and get incorporated into the newly synthesized double stranded DNA.  As each cycle of 
amplification is completed, the fluorescent intensity of that DNA is measured and recorded.  
These data can be used to detect DNA to compare relative DNA abundance to other samples.   
 
Section 3: Real Time Quantitative PCR to determine microRNA expression levels 
 In order to quantify and explore microRNA in other tissues, the RNA was extracted from 
those tissues, complementary DNA (cDNA) was made from that RNA using reverse 
transcriptase and the resulting DNA was then used as a template in RT-qPCR reactions.   
The microRNA was initially isolated from tissue by homogenizing the tissue in Trizol.  Trizol is 
a reagent that extracts DNA, RNA, and protein (Chomczynski and Sacchi, 2006). RNA was then 
isolated using isopropyl alcohol precipitation.  
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 Reverse transcription of the RNA precipitate was completed using Qiagen’s  miRscript 
RT kit  (one hour incubation at 37degress Celsius, followed by a 5 minute incubation at 95 
degrees Celsius, and stored at 4 degrees Celsius).  
  The cDNA were then used as templates in RT-qPCR to quantify microRNAs.  The 
fluorescent intensity of these cDNAs were compared to endogenous microRNA cDNAs that are 
known to be expressed in all cells: Sno25 and Let7a.  
BioRad iQ SYBR Green supermix was used to fluorescently label the microRNA cDNA under 
the following RT-qPCR conditions  
95°C 15 min 
 95°C 15 sec  
55° C 30 sec 
72° C 30 sec  
4° C ∞  
 
Section 4: Luciferase Assay 
 A luciferase assay can be used to determine if a region of DNA has promoter activity.  
The luciferase gene (responsible for luminescence in fireflies) has been isolated and cloned into a 
vector called pGL3.  The pGL3 vector also contains essential plasmid elements: an origin of 
replication, a multiple cloning site, the ampicillin resistance gene (beta lactamase), and the 
luciferase gene (Figure 2.3).  There are three types of pGL3 constructs that were used in these 
experiments: pGL3 Basic, pGL3 Control, and three pGL3 constructs A, B, and C. 
 PGL3 Basic serves as a negative control for the luciferase assay.  This plasmid has all of 
the necessary elements of the vector (an origin of replication, a multiple cloning site, the 
39 cycles 
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ampicillin resistance gene (beta lactamase), and the luciferase gene) but lacks the promoter 
region for the luciferase gene.  With no promoter region, the luciferase enzyme cannot be 
transcribed or translated.  The pGL3 plasmid contains the identical elements of pGL3 Basic, but 
also has the SV40 promoter positioned in front of the luciferase gene.  The SV40 promoter is 
derived from the SV40 virus and is transcriptionally active in eukaryotic cells. The experimental 
plasmid constructs pGL3 A, B and C are made by inserting the DNA of interest into the multiple 
cloning site of the pGL3 Basic vector in front of the luciferase gene.  If any of these DNA inserts 
have promoter activity they will drive the expression of the luciferase gene. These constructs are 
referred to as A, B, and C to indicate the three different DNAs that were cloned into this vector.  
Figure 2.5 
 
 The pGL3 Basic vector that will be used to clone DNA sequences of interest is diagrammed above.  The 
multiple cloning site is shaded grey and is positioned in front of the luciferase gene (shaded orange/yellow).  The 
beta lactamase gene conferring ampicillin resistance is opposite the luciferase gene 
The pGL3 constructs will be transfected into wild type keratinocyte cells and luciferase 
activity will be measured.  The protein product produced from these constructs is a recombinant 
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luciferase enzyme, which catalyzes beetle luciferin to oxyluciferin (Promega Technical Manual) 
(Details of this reaction can be found in the Appendix, Section 5).  Luciferase activity will be 
specifically assayed by lysing the cells 48 hours after transfection, adding beetle luciferin to the 
lysed cells and measuring the production of oxyluciferein by a luminometer.   
 Promega’s Dual Luciferase Reporter Assay System utilizes both the pGL3 firefly 
luciferase vector and a renilla luciferase plasmid. These two luciferase enzymes, recombinant 
firefly luciferase and renilla luciferase, bind different substrates and produce different products 
(See the Appendix, Section 5).  Both products can be detected by a luminometer. This dual 
luciferase assay, provides an internal transfection control.   Essentially, if the ratio between 
recombinant firefly luciferase and renilla luciferase is detectably different, then that difference 
suggests the promoter activity from the pGL3 construct.  Renilla Relative Fluorescent Units 
(RFU, detected by the luminometer) provide a standard fluorescent unit to compare the 
fluorescence of all of the pGL3 controls and constructs.   
Renilla and pGL3 plasmids were co-transfected into wild types keratinocytes for 48 hours 
using MiRus TransIT LT1 transfection agent.  MIGR effector plasmid was also used as a 
transfection control to determine transfection efficiency. This plasmid contains green fluorescent 
protein (GFP) under the control of a viral promoter.  If the transfection was successful, the GFP 
gene would be transcribed and translated inside the cell and be easily detected  
 
Section 5: Molecular Cloning 
 Three pGL3 constructs were made with using different potential promoter regions of 
miR-205.  All constructs were made by:  
A. Creating an insert (using a plasmid created for miR-205 knock-out, as a template); 
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B. Restriction enzyme digestion of the insert and vector with HindIII and Nhe1 to create 
complementary ends; 
C. Ligating the insert into pGL3 Basic plasmid using NEB’s Quick ligase (incubating at 
room temperature for 10-15min);  
D. Transforming the plasmid into JM109 competent cells: 10min incubation on ice, 
45sec heat shock at 42 degrees C, 2 min incubation on ice.  The cells were then plated 
on ampicillin positive plates for 12-16 hours;  
E. Selecting positive colonies on ampicillin agar plates; 
F. Verification of the constructs was done by isolating plasmid DNA from the 
transformed cells, and restriction digest analysis of those plasmids to confirm proper 
length and orientation;   
G. All final constructs pGL3 A, B, and C were sequenced to verify the sequence, length 
and orientation of the insert.   
Figure 2.6: Demonstrates the importance of proper orientation of the insert into pGL3 Basic 
 
As shown in Figure 2.4, if the promoter DNA was ligated in pGL3-Basic in the counterclockwise direction, 
the luciferase gene will not be transcribed and no luminescence will be detected.  The pink lightning bolts 
indicate the restriction enzyme (R.E.) sites where the insert was ligated into the plasmid.  The red arrow 
Screening
• After ligation: Insert verification!
– Size
– Directionality in ligated constructs
– PCR vs. RE cutting for insert
Luciferase Gene
miR-205 promoter
PGL3-basic R.E. Sites
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indicates the predicted promoter region. The luciferase gene is highlighted in yellow showing the direction 
of transcription (clockwise).   
In pGL3 205 A, the insert was created by enzyme digestion of the target plasmid. The 
target plasmid had HindIII sites flanking 8.302 Kilo basepairs (KB) that was the target region.  
This region was isolated after digestion and was then ligated with both ends of the insert 
complementary to the HindIII site in the vector. PCR screening was necessary to determine 
proper orientation. Primers were created to  
 In the second construct, pGL3 205B the insert was 3.5KB. PCR reaction was used to 
generate the DNA insert utilizing primers that contained the appropriate restriction enzyme sites.  
For example the 5’ primer used for PCR had an Nhe1 site, whereas the 3’ end of the insert was 
amplified by a primer that contained a HindIII site.  The insert was cut with Nhe I and Hind III 
and then ligated into the multiple cloning site of pGL3 Basic  (which had been cut with NheI and 
Hind III). 
Due to the GC rich sequence 10% DMSO was needed in the PCR reaction to obtain a 
product.  Standard PCR conditions were used along with New England Biolab’s  (NEB) phusion 
enzyme and HF buffer.   
The PCR conditions used to generated the DNA inserts were as follows:  
98°C 15 min 
 98°C 15 sec  
56° C 30 sec 
72° C 30 sec  
4° C ∞  
35 cycles 
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The method used to create the insert for construct pGL3 205C was identical to that of 
construct pGL3 205B except that a different 3’ primer was used to create a shorter DNA insert 
(2.7KB).  
 
Chapter 3 Results: 
Section1: MiR-203 Expression Pattern 
MiR-203 is expressed in differentiated cell lineages including the suprabasal layer (SB), 
the sebaceous gland (SG), the inner root sheath (IRS), and the pre-cortex fork (PCF). NBT/BCIP 
in situ hybridization has confirmed these expression patterns, but further clarification using FISH 
is needed to distinguish the expression of this microRNA in the epidermis.  These hybridization 
experiments also need to be done with a negative control so that artifacts of the in situ procedure 
could be ruled out and relative background noise will be visible. 
Figure 3.1  
Illustration of the observed miR-203 Expression 
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A. NBT/BCIP in situ hybridization 
 The different cell lineages were labeled as described in the Materials and Methods 
section.    
 Figure 3.2 
MiR-203 NBT/BCIP
 
 MiR-203 Expression in Postnatal day 6 (P6) mice: A) Negative control at 10x magnification 
lacking the probe B) Hybridization using miR-203 probe at 10x magnification, dark staining regions 
indicate strong miR-203 expression in the epidermis, specifically the suprabasal layer (SB). C) 
Hybridization using miR-203 probe 20x magnification the dark areas indicate strong expression of miR-
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203 in the suprabasal layer.  The signal in the basal layer needs to be clarified with FISH for further 
verification. This image also shows miR-203 expression in the sebaceous gland (SG).  The inner root 
sheath is also visible.  D) Hybridization using miR-203 at 63x magnification: This image shows the 
expression of miR-203 in the basal and suprabasal layer E) Hybridization using miR-203 probe at 20x 
magnification: miR-203 expression is visible in the inner root sheath, pre-cortex fork, and the matrix F) ) 
hybridization using miR-203 probe at 63x magnification:  miR-203.is clearly expressed in the PCF and 
stems from the inner root sheath.  
  
B. Fluorescent in situ hybridization: 
FISH was used to clarify the expression of miR-203 in the epidermis of postnatal day 6 
(P6) mice. The FISH technique allows the investigator to visualize the sub-cellular localization 
of miR-203 (labeled with a green fluorescent tag) as well as other fluorescently tagged molecules 
including Beta-4 integrin (red) and the nucleus (blue). MiR-203 is preferentially expressed in the 
suprabasal layer (Figure 3 panel E). The negative control (Figure 3 Panel A) is back skin isolated 
from an miR-203 conditional knock out (DGCR8, see Materials and Methods).  These mice lack 
one of the complexes used in microRNA biogenesis.  No mature microRNA should be expressed 
in epidermis isolated from these mice.   
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Figure 3.3 
MiR-203 Fluorescent in situ hybridization 
 
MiR-203 Expression in Postnatal day 6 (P6) mice: A) FISH results at 20X magnification using 
back skin isolated from DGCR8 knock out mouse.  B) FISH results at 20X magnification indicating the 
general expression pattern of miR-203, beta 4-integrin expression in the suprabasal layer, inner root 
sheath, and the pre-cortex fork. C) FISH results at 20X magnification shows the expression of miR-203 in 
the suprabasal layer.  The beta-4 integrin staining is weak but the basal layer is located above the white 
line in the image.  D) FISH results at 20X magnification verifies the expression of miR-203 in the PCF.  
E) FISH results at 63X magnification indicating that miR-203 is specifically localized to the suprabasal 
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layer.  The labeling of SB and B marks the distinction in expression between the two layers. F) FISH 
results at 63X magnification shows miR-203 expression is further verified in the PCF, and localized in the 
inner root sheath of the hair follicle adjacent to the labeled matrix.  The inner root sheath is distinct 
because its cell shape is long and skinny, this image supports but does not confirm the expression of miR-
203 in the inner root sheath.  
 
Section 2: MiR-143 Expression Pattern 
 MiR-143 is expressed in matrix cells and minimally expressed in the epidermis, 
specifically the suprabasal layer (Figure 3.5). The images from the FISH experiment (Figure 3.6) 
support the observed expression of miR-143 in matrix cells, with minimal expression in 
suprabasal layer. The negative control was not hybridized to any probe and therefore shows 
background signal in Figure 3.5.  
Figure 3.4 
Illustration of observed miR-143 Expression 
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A. NBT/BCIP in situ hybridization 
Figure 3.5 
MiR-143 NBT/BCIP 
 
Note:  These samples are slightly underdeveloped so the abundance of microRNA may not be reflected 
accurately by the signal strength. MiR-143 Expression in Postnatal day 6 (P6) mice: A) Negative control 
no probe was added to this slide.  B) MiR-143 expression at 10x magnification: evident in the matrix and 
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slightly expressed in the epidermis C) Epidermis from back skin at 20x magnification: this image shows 
minimal miR-143 expression in the epidermis.. D) Matrix from back skin at 63x magnification 
demonstrating that miR-143’s expression is uniform in the matrix.  
B. Fluorescent in situ hybridization (FISH) 
 MiR-143 is expressed in the matrix of developing hair follicles.  MiR-143 shown in 
green, nucleus is stained with Hoechst (blue).  The hair shafts in these pictures have auto 
fluorescence.  Non-specific signals can be seen in the bright hair shafts and the stratum corneum 
(SC) (a layer of dead epidermal cells). The negative control is a Dicer conditional knock out, 
with the probe added.  This is another important molecule involved in microRNA biogenesis.  
No genuine expression is detected.  
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Figure 3.6.  
MiR-143 Fluorescent in situ hybridization 
 
 
MiR-143 Expression in Postnatal day 4 (P4) mice: A) Negative control Dicer: No expression as 
expected. B) Epidermis and hair follicle at 10x magnification which shows minimal expression of miR-
143 localized to the suprabasal level.  The matrix cells are dense and in this image, the signal appears to 
be masked. C) Epidermis at 20x magnification showing minimal expression of miR-143 localized to the 
suprabasal cells. D) Matrix at 20x magnification indicates possible expression of miR-143 in the matrix.  
The background noise is high in this image.  E) Confocal image of Dicer control at 100x magnification: 
This image is used to determine the background fluorescence. The bright green dots are non-specific 
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signals as they are localized in the nucleus and cytoplasm (mature microRNAs are located in the 
cytoplasm).   F) Confocal image of wild type back skin at 100x magnification confirming uniform 
expression of miR-143 in the matrix 
 
C. Embryonic Expression 
 MiR-143 is not only expressed in skin tissue but in embryonic tissues as well. Embryonic 
tissue was isolated from mice at embryonic day 17.5 (E17.5).  Both NBT/BCIP and FISH 
indicated that there is expression of miR-143 in the heart and possibly the stomach.  Further 
validation of expression in the stomach is needed because there could be endogenous expression 
of alkaline phosphatase and peroxidase in this tissue.  Alkaline phosphatase and peroxidase are 
the enzymes that are attached to the anti-DIG probes that catalyze the reaction signals during the 
NBT/BCIP in situ hybridization.  NBT/BCIP and FISH indicate that miR-143 is expressed in the 
suprabasal layer of the epidermis and in the developing hair follicles of embryonic tissue (Figure 
3.7 Panels A, B, C, D, G, and H).  Expression is also seen in the epithelium of the stomach lining 
(Figure 3.7 Panels E and F) and smooth muscle (Figure 3.7 Panel I and J) in the heart. 
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Figure 3.7 
MiR-143 Embryonic Expression 
 
 
 
Figure 3.7: 
Embryonic tissue was isolated from E17.5 mice. 
Panels A, C, E, G, I: NBT/BCIP, Panels B, D, F, 
H, J: FISH. 
 
A, B: MiR-143 expression is seen in the 
epidermis, specifically in the suprabasal layer. 
  
C, D: MiR-143 is expressed in the bulb region in 
conjunction with minimal expression in the 
suprabasal layer.  
E, F: This is a cross-sectional view of the 
embryonic tissue in the stomach.  MiR-143 
expression is localized to the outer most 
epithelial layer.    
G, H: Whisker development shows expression of 
miR-143 in the hair follicles and minimally in the 
epidermis.  
I, J: The tissue to the left side is the heart/smooth 
muscle of the heart.  To the right is a rib. MiR-
143 expression is localized throughout the tissue 
presumably in the smooth muscle. 
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Section 3: MiR-125b Expression Pattern 
Figure 3.8 
Illustration of Observed Expression 
 
A. NBT/BCIP in situ hybridization 
 MiR-125b is less abundantly expressed in the skin compared to miR-203.  Published data 
indicates that miR-125b is expressed in the upper outer root sheath, bulge region, and in the basal 
layer of the skin (Zhang et al., 2011).  My data supports these findings and also indicates that 
miR-125b is also expressed in the tip of the matrix.  When images of in situ hybridizations for 
miR-125b using NBT/BCIP are overexposed the miR-125b signal in the matrix is above the 
background of the negative control (Figure 3.9) 
 
 
Basal 
Suprabasal 
Sebaceous Gland 
Matrix cells 
Dermal Papilla 
Inner Root Sheath 
Outer Root Sheath 
miR-125b Observed Expression 
Bulge 
 44 
Figure 3.9  
MiR-125b NBT/BCIP 
 
 
 
 
 
Figure 3.9 
The tissue in this figure was isolated from the 
back skin of P6 mice.  
A) Negative control at 10x magnification to 
detect background noise in these images.  
The background noise is high indicating 
overdevelopment. 
 B) Epidermis and hair follicle at 10x 
magnification: indicating miR-125b 
expression in the epidermis, the outer root 
sheath, and the tip of the matrix. 
 C) Epidermis at 20x magnification: miR-
125b expression is seen in the outer root 
sheath close to the epidermis with the signal 
being stronger in the basal cells of the 
epidermis.   
D) Epidermis at 63x magnification: 
indicating miR-125b minimal (possible non-
specific) expression in the suprabasal layer 
and strong expression in the basal layer. 
E) Matrix at 20x magnification: indicating 
some miR-125b expression in the tip of the 
matrix.  
F) Matrix at 63x magnification indicating: 
miR-125b expression at the tip of the matrix.  
The signal decreases in intensity at the 
center of the matrix. 
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Section 4: MiR-205 Expression Pattern 
   
Figure 3.10 
Illustration of Observed Expression 
 
A. NBT/BCIP in situ hybridization 
MiR-205 is expressed in undifferentiated skin cell lineages including the basal layer and 
outer root sheath.  The images below show the expression patterns of miR-205 using NBT/BCIP 
in situ hybridization and FISH.   
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Figure 3.11 
  MiR-205 NBT/BCIP 
 
 
B. Fluorescent in situ hybridization/ Confocal Images 
Postnatal expression of miR-205 has been characterized in epidermal mouse tissue; 
however no expression pattern has been determined for embryonic hair follicle morphogenesis.  
MiR-205 is actively expressed in all stages of hair follicle morphogenesis: two layer epidermis, 
hair peg, hair germ, and hair follicle. FISH images were generated using confocal microscopy to 
enhance localization detail of the miR-205 signal.  Samples were co-stained with beta-4 integrin 
(red) to show the separation between the epidermis and dermis. The nucleus is stained (blue) 
with Hoechst dye and miR-143 is seen in green.  
Figure 3.11 
Tissue was isolate from the back skin of P6 
mice. 
A) Negative control at 10x magnification to 
detect background noise in these images 
B) Epidermis and hair follicles at 10x 
magnification: indicating miR-205 
expression in the epidermis, and hair 
follicle.  
C) Epidermis at 20x magnification: miR-
205 expression is seen in both layers of the 
epidermis and the outer root sheath.  
D) Epidermis at 63x magnification: 
indicating miR-205 expression in the basal 
layer with possible non-specific expression 
in the suprabasal layer.    
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Figure 3.12  
MiR-205 Fluorescent in situ hybridization  
 
Tissue was isolated from mice at embryonic day 14.5 (14.5): A) Epidermis 100x magnification: 
shows expression of miR-205 in early epidermal development.  B) Invaginating hair germ at 100x 
magnification: shows miR-205 expression as hair follicles begin to form. MiR-205 expression is seen in 
the basal layer as the epidermis invaginates into dermis. C) Invaginating hair germ at 100x 
magnification: miR-205 expression is seen as the hair germ matures. D) Developing hair peg at 100x 
magnification: indicates miR-205 expression in the hair peg extending down into the dermis E) 
Developing hair peg including epidermis at 100x magnification: demonstrating miR-205 expression in 
the epidermis residing in the basal layer. F) Upper hair follicle at 100x magnification: the bulge region is 
located in the outlined follicle toward the top of the image and miR-205 expression is clearly seen here as 
well as in the outer root sheath.  
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C. Embryonic Expression  
MiR-205 is expressed in other embryonic tissues in addition to the skin including the 
liver, forebrain, sinuous, and eye region.  
Figure 3.13  
MiR-205 Embryonic NBT/BCIP 
 
 
These samples were isolated from embryonic day 14.5 mice. A) Epidermis at 10x magnification: 
shows that miR-205 expression is localized to the epidermis.  B and C) Developing hair follicles at 10x 
magnification: shows that miR-205 is expressed in epidermal back skin (B) and facial epidermis forming 
whiskers (C).  D) Eye region at 10x magnification: shows that miR-205 is highly expressed here.  E) 
Sinuous at 10x magnification: shows that miR-205 is highly expressed in the sinuous and is localized to 
the outer lining with decreasing signal toward the center.  F) Liver at 10x magnification: shows miR-205 
is uniformly and minimally expressed in the liver.  
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is uniformly and minimally expressed in the liver.  
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D. Quantification of miR-205 tissue exploration 
Using NBT/BCIP in situ hybridization, miR-205 is expressed in other embryonic and 
postnatal tissues in addition to the skin. To verify the observed expression by NBT/BCIP, rt-
qPCR was used to quantify relative microRNA abundance.  Figure 3.14 and 3.15 show the 
relative fold expression of miR-205 expression in various tissues. The internal controls for this 
experiment were the endogenous microRNAs expressed in all cells, sno25 and let7.  
Figure 3.14  
Relative Expression of miR-205 in Different Tissue Types in Postnatal Day 10 Mice 
 
MiR-205 is abundantly expressed in the skin and minimally expressed in the lungs. The linear Y-
axis shows the abundance and relative expression of miR-205 
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Figure 3.15  
Relative Expression of miR-205 in Different Tissue Types in Postnatal Day 10 Mice  
(Log Base 2) 
 
  Using a log scale to diagram the expression of miR-205, additional expression in the brain and 
heart are observed. When the expression of miR-205 in wild type tissues is compared to the same tissue in 
the knock out mice, the only observable difference in miR-205 expression is seen in the skin and lung 
tissue. 
Section 5: Luciferase Assay 
 Luciferase assays were used to test predicted DNA sequences thought to contain 
promoter activity. DNA was selected based on ChIp-Seq data and Evolutionary conservation.  
Three DNA sequences were tested (Constructs A, B, and C). 
 ChIP-Seq is a method that is able to sequence DNA bound to different proteins.  In this 
case, the interaction between histones and DNA is targeted.  Histones are proteins that bind to 
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DNA and wind it up in a spool to condense it.  There are various chemical marks on the histones 
that can identify different biological functions.  For example on histone 3 lysine residue 4, 
trimethylation marks DNA regions that are used for promoters.   Elongation can be identified by 
methylation on histone 3 lysine reside 36.  ChIP-Seq is therefore able to correlate the DNA 
sequence with the modifications of the histones.  This makes it accessible to compare the histone 
modifications to annotated genes. 
Figure 3.16 (Li Wang, Yi Lab) 
ChIP-Seq for miR-205 
 
 
ChIp-Seg for Histone 3 Lysine 4 trimethylation (H3K4me3) is in red.  H3K4me3 peaks can 
predict promoter regions.  The first H3K4me3 bar is ChIP-Seg from P4 mice and the second bar is from 
E14 mice.  This data predicts that there is not one distinct promoter region as shown by the multiple 
peaks at the 5’ end of the EST (blue).  The green peaks are Histone 3 Lysine 36 trimethylation marks 
(HeK36me3), this identifies active elongation of transcription. The H3K36me3 are normal because peaks 
are seen after transcription stars and close to miR-205. The EST is shown in blue (5’ is to the right, 3’ to 
the left).  MiR-205 is transcribed from right to left and shown in yellow above the blue EST.  
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A. Construct A 
Figure 3.17  
Luciferase Expression driven by Construct A  (8.3 kb region) 
 
This figure shows the conservation of important DNA sequences surrounding miR-205 gene. 
ChIP-Seq shows data suggests some promoter activity in this region. The black striped bar boxed in red, 
shows the region of DNA used to create Construct A. There are peaks of conservation at the 
transcriptional start site, slightly upstream of the transcription start site, and in the second exon all 
highlighted in yellow.  These conservation peaks suggest that these DNA sequences are conserved 
through out mammals.  
 When this DNA sequence was used in a luciferase assay, there was slight activity when 
normalized to pGL3 Basic.  PGL3 Control (SV40 promoter) and pGL3 203 (miR-203 active 
promoter) were used as positive controls to compare luciferase activity. 
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Figure 3.18 
Luciferase Assay Results Using Construct A 
 
The graph in Figure 3.18 shows the relative expression of the promoter construct A when 
normalized to the pGL3 Basic construct, which lacks a promoter insert. PGL3 205A shows minimal 
luciferase activity suggesting construct A does not contain an active promoter region. PGL3 Control and 
pGL3 203 show high luciferase activity.   
 
Figure 3.19.  Relative Florescence Unit (RFU) Values for Controls and Construct A 
Construct Luciferase RFU Renilla RFU Ratio L:R 
pgl3 basic well1 3825 20142260 0.0002 
pgl3 basic well2 5944 26310040 0.0002 
pgl3 basic well3 5596 29653018 0.0002 
pgl3 control well1 1510067 30505442 0.0495 
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pgl3 control well2 2990536 50307760 0.0594 
pgl3 control well3 2168345 31742078 0.0683 
pgl3 203 promo10 well1 1855597 25564540 0.0726 
pgl3 203 promo10 well2 2007495 25167350 0.0798 
pgl3 203 promo10 well3 1496436 24556158 0.0609 
pgl3 205 well1 13639 9840051 0.0014 
pgl3 205 well2 18559 19276952 0.001 
pgl3 205 well3 15542 15332891 0.001 
The actual luciferase RFUs from the dual luciferase assay in each of the constructs is 
shown in Figure 3.19.  The RFU from the renilla luciferase should be relatively constant for each 
sample and between each of the constructs.   
 
B. Construct B 
Construct B contain some of the same DNA as construct A, however this DNA 
sequence is further 5’ and small than construct A.  Construct B is located in the 
middle of the first intron (figure 3.20). 
Figure 3.20 
Luciferase expression driven by Construct B  (4.5 kb region) 
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This figure shows the conservation of important DNA sequences surrounding miR-205 gene. 
ChIP-Seq shows data suggests some promoter activity in this region. The black striped bar boxed in red, 
shows the region of DNA used to create construct B. There are peaks of conservation at the 
transcriptional start site and slightly upstream of the transcription start site highlighted in yellow.  These 
conservation peaks suggest that these DNA sequences are conserved through out mammals. Notice 
construct B is located 5’ of Construct A (Figure 3.17) and includes DNA in the intron showed in purple. 
This DNA region was used in a luciferase assay to determine its promoter activity.  As 
shown in Figure 3.21, construct B negatively affects luciferase activity and suggests that this 
DNA fragment does not drive the expression on miR-205.  
Figure 3.21  
Luciferase Assay Results Using Construct B 
 
The graph in Figure 3.21 shows the relative expression of the promoter construct B when 
normalized to the pGL3 Basic construct, which lacks a promoter insert. PGL3 205B has less luciferase 
activity thank pGL3 Basic (negative control).  This suggests that the intron could negatively affect the 
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translation of luciferase gene if it is not spliced (normally introns are cut out before translation). PGL3 
Control and pGL3 203 show high luciferase activity.   
Figure 3.22  
 RFU Values for Controls and Construct B 
Construct Luciferase RFU Renilla RFU Ratio L:R 
pgl3 basic  12372 39099516 0.0003 
pgl3 basic  9410 19983272 0.0005 
pgl3 basic  14030 34674184 0.0004 
pgl3 control  1034377 30009482 0.0345 
pgl3 control  1126704 36774684 0.0306 
pgl3 control  776183 25665536 0.0302 
pGL3 203 2488136 28746380 0.0866 
pGL3 203 1791440 23917484 0.0749 
pGL3 203 1704125 22659524 0.0752 
pgl3 205B 771 14302725 0.0001 
pgl3 205B 323 9004732 0 
pgl3 205B 1062 14369534 0.0001 
 
The actual luciferase RFUs from the dual luciferase assays in each of the B constructs is shown 
in Figure 22.  The Relative Flourescence Unit (RFU) from the renilla luciferase should be 
relatively constant for each sample and between each of the constructs.   
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C. Construct C 
This DNA sequence is important because it will show if the DNA downstream of 
construct C were causing the minimal luciferase activity.  Construct C included the 
transcriptional start site and DNA upstream of that.  No DNA downstream of the transcription 
start site is included (Figure 3.23). 
Figure 3.23 
Luciferase expression driven by Construct C  (2.7 Kb region) 
 
This figure shows the conservation of important DNA sequences upstream of miR-205 gene. 
ChIP-Seq shows data suggests some promoter activity in this region. The black striped bar boxed in red, 
shows the region of DNA used to create construct B. There are peaks of conservation slightly upstream of 
the transcription start site (blue) highlighted in yellow.  These conservation peaks suggest that these DNA 
sequences are conserved through out mammals. Construct C starts at the transcriptional start site boxed 
in blue.  This is the beginning of the first exon.  
This DNA region was used in a luciferase assay to determine its promoter activity.  As 
shown in Figure 3.24, construct C has minimal luciferase activity.  Both construct A and C were 
used to compare general luciferase activity in the same experimental settings.  Figure 3.24 shows 
that there is not a large different between the two constructs and that they have minimal 
luciferase activity compared to pGL3 Basic.  
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Figure 3.24  
Luciferase Assay Results Using Construct C 
 
The graph in Figure 3.24 shows the relative expression of the promoter C constructs when 
normalized to the pGL3 Basic construct, which lacks a promoter insert. The luciferase activity of 
construct A compared to construct C shows that pGL3 205A has1.4 fold higher activity than pGL3 205C.  
The pGL3 control vector (SV40 promoter) is much higher than pGL3 205A and C promoter regions.  This 
data suggests that the A and C constructs have similar activty levels, which are low compared to the 
pGL3 Control.   
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Figure 3.25    
RFU Values Comparing Controls, Construct A, and C 
Construct Luciferase Renilla Ratio L:R 
pGL3 Basic 58561 34906128 0.0017 
pGL3 Basic 53682 28542632 0.0019 
pGL3 Basic 38285 19927378 0.0019 
pGL3 Control 14214210 26453000 0.5373 
pGL3 Control 15047384 25522226 0.5896 
pGL3 Control 17376206 40552072 0.4285 
pGL3 205A 270221 14268403 0.0189 
pGL3 205A 166481 6831116 0.0244 
pGL3 205A 356806 25131206 0.0142 
pGL3 205C 133942 9216099 0.0145 
pGL3 205C 141647 7508077 0.0189 
pGL3 205C 277038 16905292 0.0164 
The actual luciferase RFUs from the dual luciferase assays in A and C constructs is shown in 
Figure 25.  The Relative Flourescence Unit (RFU) from the renilla luciferase should be relatively 
constant for each sample and between each of the constructs.   
 
 D. 293T Luciferase Assay 
Construct C was also transfected into human embryonic kidney cells (293T cells, also 
referred to as BOC cells). Using Northern Blot assays, the Yi lab has determined that miR-205 is 
not expressed in these cells, but miR-203 is expressed.  Since miR-205 is not expressed in this 
cell line, any luciferase activity will from pGL3 205C will demonstrate baseline detection of this 
DNA, suggesting it is not an active promoter region.  
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Figure 3.26  
Luciferase Assay Results of Construct C in BOC Cells 
 
The graph in Figure 3.26 shows the relative expression of the pGL3 203 and 205C when 
normalized to the pGL3 Basic construct, which lacks a promoter insert. The luciferase activity of. the 
pGL3 control is much more active in BOC cells than in keratinocytes.  Different promoter activity levels 
for the same construct have been observed in different cell lines.  The pGL3 control is 4,177 fold more 
active than pGL3 203 construct,. This suggests only that SV40 promoters are more avtive in BOC cells 
compared to keritinocytes. PGL3 203 has higher luciferase activty compared to pGL3 205C.  This not 
only confirms that miR-203 is activte and present in BOC cells, but also shows that pGL3 205C still has 
about a 13 fold increase in activity when normalized to pGL3 Basic.  If pGL3 205C still has minimal 
activity in BOC cells (where miR-205 is not present) then it can be assumed that this “minimal” 
luciferase activty does not equate to any promoter activity. 
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Figure 3.27 
RFU Values of Construct C in BOC cells 
 
Construct Luciferase RFU Renilla RFU Ratio L:R 
pGL3 Basic 20679 7299181 0.0028 
pGL3 Basic 22652 7445225 0.003 
pGL3 Basic 19218 7494504 0.0026 
pGL3 Control 58142424 5085558 11.4328 
pGL3 Control 62676600 4816253 13.0136 
pGL3 Control 51325588 4399167 11.6671 
pGL3 203 1539185 5139493 0.2995 
pGL3 203 2056767 5132919 0.4007 
pGL3 203 1030674 3191977 0.3229 
pGL3 205 215023 6903867 0.0311 
pGL3 205 269783 6573759 0.041 
pGL3 205 251319 7046033 0.0357 
The actual luciferase RFUs from the dual luciferase assays in pGL3 203 and 205 constructs is 
shown in Figure 3.27.  The RFU from the renilla luciferase should be relatively constant for each 
sample and between each of the constructs.  
 
Chapter 4: Discussion 
 
 To shed light on the role microRNA has in differentiation of stem cells in the skin, the 
localization and expression patterns for those micro RNAs must be determined. It is known that 
microRNAs are differentially expressed in the skin.  Localization of particular microRNAs in the 
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skin will suggest a role for their function. In situ hybridization studies were used to determine the 
expression patterns of miR-143, miR-125b, and miR-205 in skin tissue. MiR-203 was used as a 
positive control in these hybridizations. 
Section 1: In Situ Hybridization  
Both NBT/BCIP and FISH methods were used to detect microRNA in various epithelial 
tissues. The hybridization patterns with NBT/BCIP can be utilized to understand the general 
expression pattern of microRNAs, but overdeveloped samples can show potential non-specific 
expression.  The FISH technique is useful in that it can validate the preferential expression of 
microRNA seen in NBT/BCIP and can also detect the sub-cellular localization of microRNAs in 
the samples being tested.  
A. MiR-203’s Expression Pattern: 
 MiR-203 has a distinct expression pattern localized to the suprabasal cells in the 
epidermis as well as to the inner root sheath, sebaceous gland, and pre-cortex fork of the matrix. 
It is interesting how distinct the expression pattern of miR-203 is in the two adjacent cell types: 
basal and suprabasal cells indicating that this microRNA might play an important role in the 
process of differentiation, or be a marker for differentiated cells.  
MiR-203 is mainly expressed in differentiated cell types (Yi et al., 2008). To determine 
the expression pattern of miR-203 in hair follicles, Postnatal day 6 mice (P6) were used.  At this 
age the hair follicles are established but have not started cycling through the hair stages. The 
bulge region in the skin of mice at this age is difficult to visualize without co-staining because 
the bulge region is still developing and is small in size. The bulge region typically becomes 
apparent before the first telogen. MiR-203 served as a positive control in many of these 
experiments because it is abundant in the hair follicle and epidermis.  
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B. MiR-143 Expression Pattern: 
 MiR-143 expression is less abundant than miR-203 as analyzed by small RNA cloning 
frequency (Yi et al., 2006).  MiR-143 is expressed in matrix cells and possibly suprabasal cells.   
Cells in the matrix are considered to be transit-amplifying (TA) cells, which means they are in 
the transition between undifferentiated and differentiated cells. These cells are highly 
proliferative and actively differentiating.  Studying expression patterns of microRNAs in skin 
tissue can provide insights into the molecular steps leading to differentiation. 
Using the results from NBT/BCIP, it is apparent that miR-143 expression is much less 
abundant than miR-203 and miR-205.  Analysis of NBT/BCIP patterns reveals miR -143 
expression in the matrix and possibly the suprabasal layer, but this needs to be confirmed FISH.   
This expression of miR-143 in the matrix is prevalent in P4-P6 mice confirmed by FISH 
and analyzed with confocal microscopy.  The FISH method indicates that there is some signal for 
miR-143 in the suprabasal cells, which could be due to non-specific expression.  The negative 
control for these FISH experiments was a Dicer knock-out, which would not produce any signal 
for microRNA since Dicer is required for microRNA biogenesis. FISH images with tissue from 
the Dicer knock-out shows non-specific expression in the stratus corneum.  This layer often 
imitates high expression even though it is actually composed of dead cells.  An examination of 
the area below the stratus corneum indicates that the suprabasal layer contains minimal 
expression of miR-143.  The difference in the intensity of the miR-143 signal compared to the 
Dicer knock-out is significant when looking at matrix cells.  MiR-143 has a much higher signal 
in the wild type tissue.  Therefore, confocal images confirm that miR-143 is expressed in the 
matrix,  
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Ideally, the expression any microRNA in the dicer knock-out should be non-existent.  
However, there were minimal non-specific signals indicated by the presence of bright green dots 
scattered in the nucleus and cytoplasm.  MicroRNAs are localized in the cytoplasm, which 
suggests that these dots are non-specific signals in the Dicer knock-outs. The remaining 
background noise can be a result of experimental procedures including hybridization 
temperatures, stringency of washes, and amplification times.  
 MiR-143’s expression was also explored in embryos that were 17.5 days old  (E17.5).  At 
this age, there are several different stages of hair follicles developing in the embryo. MiR-143 
was expressed in the suprabasal layer of multi-cellular back skin and belly skin.  Hair bulbs were 
examined at 63X magnification and the expression of miR-143 localized to the suprabasal layer 
with some expression in the outer root sheath.  
  MiR-143 expression was seen in other tissues isolated from embryos at day 17.5 
including smooth muscle in the heart and epithelial tissue in the gastrointestinal tract (Cordes et 
al., 2009) (Clape et al., 2009). The digestive and gastrointestinal tract showed miR-143 
expression from the mouth though the anus.   
 The gastrointestinal and digestive tract has endogenous phosphatase and peroxidase 
activity, which are used by the digestive system to break down food. These enzymes are also 
used for detection in in situ hybridization methods, which could explain the seemingly high miR-
143 expression in this tissue. Northern blots and RT-qPCR could be done to verify the intensity 
of the expression of miR-143 in the gastrointestinal epithelium.  
 MiR-143 is specifically expressed in matrix cells.  This population of cells is distinct 
from other epithelial cells because they are actively replicating and differentiating.  MiR-143 has 
been shown to play a role in the differentiation of smooth muscle cells and adipose tissue (Elia et 
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al., 2009) (Takanabe et al., 2008).  Perhaps the expression of miR-143 in this cell lineage implies 
that this microRNA is involved in differentiation of stem cells to terminally differentiated cells in 
multiple tissues.  
 
 C. MiR-125b Expression Pattern: 
  The results show miR-125b expression in the outer root sheath, basal cells, and tip of the 
matrix cells supporting the recent literature (Zhang et al. 2011).  In skin from P6 mice, miR-125b 
is mainly expressed in undifferentiated cell lineages.  The results show that miR-125b is 
expressed in the tip of the matrix.  However, it is difficult to determine the specific sub-cellular 
expression of microRNAs in the matrix using only the NBT/BCIP hybridization method.  It 
would be useful to see if the tip alone has isolated miR-125b expression, or if this microRNA 
resides in the outer most layer of the matrix, where the outer root sheath extends.   
 Recently, miR-125b has been shown to be expressed in the upper outer root sheath, basal 
cells, and bulge cells (Zhang et al., 2011).  Its localization in undifferentiated cell lineages 
correlates with its proposed function to regulate early bulge stem cells.  MiR-125b is thought to 
regulate the skin stem cells by inhibiting their differentiation.  However, miR-125b does not 
affect the hair follicle stem cell’s ability to maintain a population of stem cells and does not 
prevent those cells from becoming activated under stimulation (waxing) (Zhang et al., 2011).  
 These data suggest that some microRNAs can target mRNAs responsible for activation or 
inhibition of differentiation, thus fine-tuning the gene expression of those cells.  This fine-tuning 
could be modulated with potential drugs and treatments that could target stem cell development.  
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D. MiR-205 Expression Pattern:  
 MiR-205 has an abundant and distinct spatial temporal expression pattern, which is seen 
as early as embryonic day 14 (E14).  However, this microRNA may be expressed even earlier 
between embryonic days 10 and 13 (E10-E13).  The epidermis starts to form a single layer of 
cells between E9.5 and E12.5 (Blanpain et al., 2009).  The expression of miR-205’s 
characterized expression is localized to undifferentiated cells in contrast to the expression of 
miR-203. In in situ hybridization experiments, the signal for miR-205 is seen in the basal layer, 
outer root sheath, and bulge cells.  MiR-205 is expressed during the morphogenesis of the hair 
follicle.  Using the confocal microscope to examine tissue from wild type P0, miR-205 was 
localized at the tip of the invaginating hair germ and bulb.  It stays localized to the outer root 
sheath and resides in the bulge region. Therefore, miR-205 is expressed during the development 
of hair follicles.  
 In situ hybridization with NBT/BCIP was done with epithelial tissue isolated from wild 
postnatal mice age (P6).  In these samples, miR-205 is still expressed in undifferentiated cell 
types including basal cells and less abundantly in the outer root sheath and matrix cells. The 
expression of miR-205 is likely to be initiated between E10 and E14, as the epidermis develops 
hair follicles; miR-205 expression is abundant on the leading edge of hair germs as they 
invaginate into the dermis.  Later when hair follicles are still developing, miR-205 is expressed 
in undifferentiated cell lineages including basal cells, outer root sheath, and bulge cells.  
 Using NBT/BCIP in situ hybridizations with wild type embryonic tissue, miR-205 was 
shown to be expressed in the skin epidermis, the hair follicles in the head region (including 
eye/cornea expression), the liver, and the forebrain.   
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 In order to clarify the expression of miR-205 in those tissues, high quality RNA was 
isolated from skin, brain, heart, and lung from P10 mice both wild type and miR-205 knock out 
mice.  These RNAs were used as templates in RT-qPCR reactions as described in Materials and 
Methods.  Internal controls, let7a and sno25, were included (let7a and sno25 are endogenously 
expressed microRNA). The results were normalized to RT-qPCR experiments on RNAs isolated 
from knock out head skin samples.  The results confirmed that miR-205 expression was highly 
abundant in skin tissue (head skin), whereas expression in the lung was minimal.  This suggests 
that miR-205 is highly specific and abundant in the skin tissue.  
 
Section 2: Luciferase Assay  
 In situ hybridization techniques determined that miR-205 is expressed in undifferentiated 
cell types in embryonic and adult skin tissue.  To incorporate miR-205 in regulatory pathways 
involving stem cell differentiation and function, investigation of the promoter region is 
necessary.  Promoter regions are important DNA sequences that drive the expression of various 
genes and microRNA.  The location of miR205’s promoter will be useful in determining how 
this microRNA is regulated.  
 The UCSC Genome Browser and ChIP-Seq data were used to identify possible DNA 
sequences that might contain high promoter activity (Figure 3.16 and 3.17).  MiR-205 is located 
in an exon of AK014513, an expressed sequence tag (EST) that has no recorded function (UCSC 
Genome Browser).  Interestingly, miR-205 is located in a region flanked by 270KB that contain 
no other annotated genes. In addition, there is minimal evolutionary conservation scores several 
KB upstream of miR-205’s transcriptional start site. The DNA flanking miR-205 has many 
regulatory elements (open reading frames, stop codons, introns, etc.) that could potentially 
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inhibit the presence of these surrounding sequences. This suggests that the miR-205 gene does 
not get translated and is positioned in the genome to insure transcription and processing into a 
mature microRNA.  
  Conventional promoters are located upstream of the transcription start site where various 
transcriptional machinery factors can be recruited to initiate transcription.  Potential promoters 
for miR-205 were isolated from DNA upstream of the miR-205 gene.  The promoter activity for 
miR-205 was hypothesized to be relatively similar to that of miR-203, which is high in 
keratinocytes isolated from mice. MiR-203 has a conventional promoter region, so it was thought 
that miR-205 would as well since both of these microRNAs are abundantly expressed in skin cell 
lineages.  
Three pGL3 constructs were made with different DNA sequences trying to find the DNA 
regions responsible for driving miR-205’s expression. These constructs were transfected into 
keratinocytes, after 48 hours luciferase activity was measured.  
 Construct A included several KB upstream of the transcriptional start site and DNA into 
the second exon right up to the miR-205 gene.  Luciferase assays were used to determine the 
promoter activity of this construct.  Promoter activity was normalized to the pGL3 basic 
construct, which lacked a promoter for the luciferase enzyme. Construct A showed a 5.6fold 
increase in promoter activity when compared to pGL3 basic.  The expected promoter activity 
was hypothesized to be similar to positive controls, pGL3 control and pGL3-203, assuming miR-
205 had a conventional promoter region.  The relative fold change in luciferase expression 
between pGL3 control and pGL3 205 A was 290 demonstrating that the DNA in construct A did 
not have strong promoter activity.  
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Another promoter assay showed that construct B does not drive the expression of the 
luciferase gene.  The relative fold change in luciferase activity between pGL3 basic and pGL3 
205B was -.16. The activity of construct B suggests that this DNA may inhibit the expression of 
miR-205.  Possible reasons for this DNA segment having a negative affect on the luciferase 
activity may be due to the interrupted intron in this sequence.  Construct B contains DNA 
upstream of the transcriptional start site through the first intron.  It is possible that the 
fragmented intron gets transcribed and represses activity of luciferase product.  The DNA in 
construct B contains three open reading frames in the intron fragment.  With each open reading 
frame, there is usually a stop codon downstream.  If the intron is not spliced, these stop codons 
could potentially inhibit the translation of the luciferase gene, thus reporting no luciferase 
activity. However, this could also be experimental error.  A repeated luciferase assay using 
construct B would be informative.  
  In the following assay, both construct A and C were tested to compare their promoter 
activities.  Construct C included DNA immediately upstream of the transcriptional start site for 
miR-205. PGL3 205C showed minimal expression, 8.7 fold, over pGL3 basic. This implies that 
the region of DNA in construct C could have minimal promoter activity.  Construct A showed 
similar luciferase activity, 10 fold over basic, thus construct A had 1.3fold expression over 
construct C.  Both constructs show minimal activity relative to pGL3 control.  
 To determine if the minimal luciferase activity in constructs A and C are genuine, another 
luciferase assay was conducted in 293T cells rather than keratinocytes. Construct C was 
transfected into human embryonic kidney cells (293T cells, also referred to as BOC cells).  The 
293T cells have minimal to no miR-205 expression; (Yi, personal communication) thus the 
promoter activity for miR-205 in these cells should be null.  PGL3 205C had minimal activity in 
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these cells, 12.8fold activity of pGL3 basic, similar to the previous luciferase assays.  This 
experiment proves that there may be minimal miR-205 expression in these cells as well as 
demonstrating that constructs A and C are minimally active in tissues that do not have high miR-
205 expression. Unfortunately it is not accurate to associate the promoter activity with the level 
of transcription of a gene. Some transcripts may be more stable and therefore do not need 
additional promoter activity.  Thus, from this assay we can only conclude that the isolated 
promoter regions for miR-205 are minimally expressed in cells that have high and low 
expression of miR-205.  
These results suggest that the region upstream of the transcriptional start site does not 
have strong promoter activity.  There is some promoter activity however it was much less than 
expected.  The promoter, or other enhancing elements, may be located elsewhere.  There is about 
500KB surrounding miR-205 without any other genes.  This suggests that there may be 
important sequences in at a large distance from the transcriptional start site.  It is possible for 
DNA further upstream of miR-205 to loop around and act as enhancing elements or essential 
promoter sequences. Therefore, constructs A and C do have minimal promoter activity, however 
since it is less than expected it is hypothesized that the true promoter and enhancer regions are 
located in the DNA surrounding miR-205.  
Section 3: Conclusion 
 MicroRNAs are small non-coding RNAs that are present in many tissues and serve a 
wide variety of functions including stem cell regulation. It is known that microRNAs have 
differential expression in mouse skin making this an ideal system to study the role of micro 
RNAs in the differentiation of stem cells.  Understanding microRNA expression can help 
elucidate their role in the maintenance and differentiation of skin and hair follicle stem cells.  An 
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integral part of exploring microRNA function, is determining their distinct location and 
expression pattern in cell lineages. The microRNAs: miR-203, miR-143, miR-125b, and miR-
205, have different expression patterns in epithelial tissue, which may suggest they have 
different functions in those cells.  MiR-205 is expressed in differentiated cell lineages, 
suggesting that it may function by either promoting “stem-ness” or inhibiting differentiation.  
 Characterizing the promoter region of miR-205 is essential to understanding how this 
microRNA is transcriptionally regulated and can help lead to identifying possible regulatory 
factors that interact with this promoter. This microRNA could be implicated in multiple cellular 
mechanisms that control the fate of stem cells. The results indicate that miR-205 does not have a 
conventional promoter region located near the transcriptional start site.  The promoter activity 
surrounding the transcriptional start site was much less than expected and it is therefore predicted 
to be located within a large region of DNA upstream of miR-205.  Finding the promoter region 
will provide data for further investigation into the regulation of miR-205.  Understanding where 
microRNAs are expressed and how they are regulated are important milestones that can be used 
to discover unknown networks of stem cell regulation.   
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Chapter 6: Appendix 
  
 
Section 1: Molecular Cloning 
Construct A: 
HindIII and Xho1 Digestion: 1Kb+ ladder run on .7% agarose gel 
 
 
The top band was cut out and purified.  It was then ligated into pGL3 Basic. This insert was 
8.5Kb 
 
PCR Screen for correct orientation: 100bp ladder run on 1.5% agarose gel 
 
 
Construct A: Digested from 
Plasmid #14 205 Final Targeting: 
Cut with HindIII and Xho1 
Lane 1= 1Kb+ ladder 
Lane 2=HindIII and Xho1 digest 
Ideal band size: 
HindIII and Xho1= 8.3Kb and 
5.4Kb 
Construct A: PCR Screen with primer 
RY130pGL3Con400 and P1 205 
Colonies were isolated that contained 
potential Construct A (#1-14)  
Lane1=100Bp ladder 
Lane 16= 100Bp ladder 
Positive 
colonies=1,5,6,7,8,9,10,11,12,13 
Ideal band size=200bp 
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Two colonies (#1, #9)  with Construct A were then digested by restriction enzymes to verify the 
construct is the correct size: 1Kb+ ladder run on .7% agarose gel 
 
  
 
 
Construct A colony #1 was then digested again for further verification: 1Kb+ladder Run on a 
.7% agarose gel 
 
 
 
Construct B:  
Primers were for a smaller insert further upstream in hope to exclude open reading frames.  PCR 
amplified the insert from Plasmid #14 205 Final Targeting with 10% DMSO and HF buffer: 1 
Kb+ ladder run on .7% agarose gel 
 
Construct A:  #1 and #9 were cut with: 
Xba1/EcoRV(X&E)  and HindIII (H) 
Lane 1= 1Kb+ ladder 
Lane2= Construct A Colony #1 (X&E) 
Lane 3= Construct A Colony #1 (H) 
Lane 4= Construct A Colony #9 (X&E) 
Lane 5= Construct A Colony #9 (H) 
Ideal band sizes: 
H&E=  9.38Kb and 3.74Kb 
H= 8.5Kb and 4.8Kb 
 
Construct A: colony#1 digested with Nco1 
This cut will cut once in pGL3 near the 3’ 
end of the insert and once in the insert. 
Lane 1= 1 Kb+ ladder 
Lane 2= Construct A colony #1 Nco1 
Ideal band size: 
Nco1= 8.5Kb and 4.5 Kb 
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The new insert was Digested with HindIII and Nhe1 to be ligated into the multiple cloning site in 
pGL3.  pGL3 Basic was also cut with HindIII and Nhe1.  They were run on a .7% gel to verify 
there were no other unexpected cuts.  
 
 
 
 
The insert was ligated to pGL3 basic and transformed to Jm109 cells.  Colonies were selected 
and verified with further restriction enzyme digestions. One negative colony ( no insert was 
ligated) and three potential positive colonies labeled #1,2, and, 3 were selected.   
 
 
 
 
Construct C:  
 
Primers were made for a smaller insert starting at the transcriptional start site.  PCR amplified 
the insert from Plasmid #14 205 Final Targeting with 10% DMSO and HF buffer: 1 Kb+ ladder 
run on .7% agarose gel 
Construct B:  PCR product = new insert 
Lane 1= 1Kb+ ladder 
Lane 2= negative control- no template 
Lane 3= template- Plasmid #14 205 Final 
Targeting 
Lane 4= template= genomic DNA 
Ideal band size = 3.562 Kb 
Construct B: Verification of insert and pGL3 
pre-ligation 
Lane 1= 1Kb+ ladder 
Lane 2= pGL3 Basic cut with HindIII and Nhe1 
Lane 3= Insert cut with HindIII and Nhe1 
Ideal band sizes: 
pGL3 Basic= 4.8Kb 
Insert= 3.5Kb 
Construct B: Digestion verification for 
correct size of construct B.  Digested with 
HindIII and Nhe1.  
Lane 1= 1Kb+ ladder 
Lane 2= negative colony 
Lane 3= colony #1 
Lane 4= colony #2 
Lane 5= colony #3 
Lane 6= colony #4 
Colonies #3 and 4 were positive for the 
proper insert 
Ideal band sizes= 4.8Kb an 3.5 Kb 
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The new insert was Digested with HindIII and Nhe1 to be ligated into the multiple cloning site in 
pGL3.  pGL3 Basic was also cut with HindIII and Nhe1.  They were run on a .7% gel to verify 
there were no other unexpected cuts.  
 
 
 
The insert was ligated to pGL3 basic and transformed to Jm109 cells.  Colonies were selected 
and verified with further restriction enzyme digestions. One negative colony ( no insert was 
ligated) and three potential positive colonies labeled #1,2, and, 3 were selected. 
 
 
 
 
 
 
 
 
 
 
 
 
Construct C:  PCR product = new insert 
Lane 1= 1Kb+ ladder 
Lane 2= DISMISS- not for this experiment 
Lane 3= PCR product  
Lane 4= PCR product repeat 
Ideal band size = 2.7 Kb 
Construct C: Verification of insert and pGL3 
pre-ligation 
Lane 1= 1Kb+ ladder 
Lane 2= pGL3 Basic cut with HindIII and Nhe1 
Lane 3= Insert cut with HindIII and Nhe1 
Ideal band sizes: 
pGL3 Basic= 4.8Kb 
Insert= 2.7Kb 
Construct C: Digestion verification for 
correct size of construct C.  Digested with 
HindIII and Nhe1.  
Lane 1 and 11= 1Kb+ ladder 
Lane 2= negative colony 
Lane 3= colony #1 
Lane 4= colony #2 
Lane 5= colony #3 
Lane 6= colony #4 
Lane 7= colony #5 
Lane 8= colony #6 
Lane 9= colony #7 
Lane 10= colony#8 
Lane 11= colony #9 
Lane 12= colony #10 
 
Colonies #2,5,6,7,8,and 10 were positive for 
the proper insert 
Ideal band sizes= 4.8Kb an 2.7 Kb 
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Section 2: In Situ Hybridization Trouble Shooting 
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Section 3: Helpful Diagrams 
Figure 5.1. 
 
Figure 5.2 
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Figure 5.3 
 
In Situ Hybridization 
Important Wash Steps 
 
 
 
Paraformaldehyde 
 
Preserves tissue,  
prevents loss of cellular RNA, 
 and stops endogenous reactions 
by Cross-linking amino acid R groups 
(Basyuk et al., 2000) 
 
 
Proteinase K 
 
Degrades protein to help  
Permeablize cells 
To probe during hybridization  
 
 
 
Acetylation 
Reduces background signal by  
preventing charged probes 
 from binding to tissue rather  
than miRNA(Jin and Lloyd, 1997) 
 
 
 
Hybridization of probe 
 
 
The temperature,  
Salt concentration, pH,  
nature of probe 
Can all affect annealing  
of probe to RNA(Jin and Lloyd, 1997) 
 
Formamide 
 
  Stabilizes RNA by suppressing  
RNase activity (Chomczynski, 1992) 
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Figrue 5.4. 
NBT/BCIP Reaction Details 
 
 
 
Figure 5.5. 
Luciferase and Renilla Reaction Details 
 
 
 
Image provided by: Promega Technical Manual: 
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1.A. Dual-Luciferase® Report r Assay Chemistry
Firefly and R nilla luciferases, because of their distinct evolutionary origins,
have dissimilar enzyme structures and substrate requirements. These
differences make it possible to selectively discriminate between their
respective bioluminescent reactions. Thus, using the DLR™ Assay System, the
luminescence from the firefly luciferase reaction may be quenched while
simult eously activating the luminescent reacti  of Renilla luciferase.
Firefly luciferase is a 61kDa monomeric protein that does not require post-
translational processing for enzymatic act v ty (1,2). T us, it functions as a
genetic reporter immediately upon translation. Photon emission is achieved
through oxidation of beetle luciferin in a reaction that requires ATP, Mg2+ and
O2 (Figure 1). Under conventional reaction conditions, the oxidation occurs
through a luciferyl-AMP intermediate that turns over very slowly. As a result,
this assay chemistry generates a “flash” of light that rapidly decays after the
substrate and enzyme are mixed.
Many of our Luciferase Assay Reagents for quantitating firefly luciferase
incorporate coenzyme A (CoA) to provide more favorable overall reaction
kinetics (3). In the presence of CoA, the luciferase assay yields stabilized
luminescence signals with significantly greater intensities (Figure 2) than those
obtained fr m the conventional a say chemistry. The firefly luciferase assay is
extremely sensitive and extends over a linear range covering at least seven
orders of magnitude in enzyme concentration (Figure 3). 
Renilla luciferase, a 36kDa monomeric protein, is composed of 3%
carbohydrate when purified from its natural source, Renilla reniformis (4).
However, like firefly luciferase, post-translational modification is not required
for its activity, and the enzyme may function as a genetic reporter immediately
following translation. The luminescent reaction catalyzed by Renilla luciferase
utilizes O2 and coelenterate-luciferin (c elenterazine; Figure 1). 
Promega Corporation · 2800 Woods Hollow Road · Madison, WI 53711-5399 USA 
Toll Free in USA 800-356-9526 · Phone 608-274-4330 · Fax 608-277-2516 · www.promega.com
Printed in USA. Part# TM040
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Figure 1. Bioluminescent reactions catalyzed by firefly and Renilla luciferases.
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Section 4: Further Explanations 
A. Hair Follicle Cycling 
There are three stages in hair follicle cycling: telogen, anagen, and catgen.  Telogen is the resting 
phase between anagen and telogen.  Anagen is the growth phase whereas catagen is the 
regression phase of the hair follicle.  These cycles are important because they occur at different 
ages in mice and have different functions therefore different microRNA expression patterns.  
Below is a more detailed description of how to characterize the hair follicle stage and at what the 
different stages are present (Figure 1,2).  
  
 
Figure 1 (Muller-Rover et al., 2001) Figure 2 (Muller-Rover et al., 2001) 
    
 
Telogen 
  Telogen is the resting stage before anagen begins.  This stage in the cycle can first be identified 
at P19 right after the first catagen (Muller-Rover et al., 2001).  This stage is usually presented 
first because it can serve as a way to orient readers before the first anagen.  It is deceiving to 
think of the first anagen so late in the murine life because mice have hair before this age.  The 
important aspect to consider is that the first hair growth is still part of hair follicle 
morphogenesis.  Telogen is considered the resting phase because there are signs that there is no 
activation for growth.  One of those signs is the size and shape of the DP cells residing below the 
hair follicle (HF).  DP cells are mesenchymal cells thought to signal growth of the HF (Muller-
Rover et al., 2001).  In telogen, there is not a complex structure of differential cell layers in the 
hair follicle.  As seen in Figure 3, there is no Inner Root Sheath (IRS).  The IRS consists of 
multiple layers of differentiated keratinocytes medial to the hair shaft.  The Outer Root Sheath 
(ORS) is present and is a barrier between the HF and the dermis.   
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Figure 3 
 
 
 
Anagen 
 Anagen is segregated into six stages.  The first two stages are easily characterized 
because the HF is still completely surrounded by dermal fibroblasts just as in telogen. To 
distinguish between these two stages, it is important to look at the involvement of the DP with 
the germ cell cap and the size of the DP cluster.  As anagen II becomes more predominant, the 
DP cluster enlarges and the germ cap starts to engulf the DP cells. Anagen III in more involved 
and is separated into three sub categories. The most important key to characterizing anagen III is 
the development and motility of the IRS. The IRS will assemble in anagen IIIa appearing as a 
cone of keratinized cells (Muller-Rover et al., 2001).  The IRS will grow up until the bottom of 
the sebaceous gland. While the IRS is forming, another group of cells becomes identifiable as 
matrix cells.   Matrix cells form the hair bulb and are known to be transit-amplifying cells.  
Matrix cells are highly proliferative and in the process of becoming differentiated into 
keratinocytes as they begin to travel up the IRS. Anagen progress in stages when the hair shaft 
enters the hair canal, and then when it emerges.  See below figures for more detail.  
 
Figure 4     Figure 5 
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Figure 6     Figure 7 
  
 
 
Catagen 
Catagen is the destruction stage of the hair follicle.  Catagen works in a similar reverse fashion 
compared to anagen.  The first steps are to decrease the size of the hair bulb and decrease the 
surrounding surface area of the hair bulb and the DP cells.  Once the hair bulb does no longer 
engulfs the DP cells, the length of the hair follicle decreases. It is lead by the regression of IRS 
cells. As the hair shaft regresses toward the surface epithelium, apoptosis increases at the bottom 
of the follicle allowing for the decreased length. Catagen is completed when the remaining IRS is 
below the sebaceous gland and when the hair germ capsule is in the dermis while the DP wells 
are directly below bordering the subcutis.  
 
Figure 8        Figure 9 
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Figure 10     Figure 11 
   
 
B. MicroRNA Function 
 When encapsulated within RISC, microRNAs function by targeting and silencing mRNA 
transcripts.  A typical target region for miRNA would be in the 3’ untranslated region (UTR) of 
the transcript. When mRNAs are transcribed, not all of the transcript will be translated into a 
protein.  The regions that are not translated are thus referred to as UTR’s.  MicroRNAs are able 
to bind specifically to these regions to inhibit translation or promote degradation. MicroRNAs 
then reduce gene expression by four mechanisms (Valencia-Sanchez et al., 2006).  See Table 1. 
 
Table 1 
Mechanism Function 
Site Specific Cleavage MicroRNA seed sequences bind to target 
mRNA causing cleavage. 
Translational Inhibition via RISC RISC is able to inhibit translational initiation 
factors.  The kinetics of RISC vs. translational 
machinery determine rate of inhibition. 
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Processing Bodies This cellular organelle degrades mRNA that is 
sequestered away from ribosomes by 
microRNA, decreasing gene expression. 
Adenine/Uricile Regulatory Sequence  This is a slicer/Ago2 independent pathway what 
is marked by adenine and uricile rich 
sequences. 
 
  
Site Specific Cleavage: This mechanism involves the endonucleatic cleavage of mRNA.  
Essentially, when the miRNA binds to the 3’ UTR of the target mRNA, specific sequences in the 
newly formed base pair between miRNA and the mRNA can trigger cleavage of the mRNA.  
Generally speaking, there are two key regions of the miRNA to consider when binding to the 
mRNA.  The 5’ end of the miRNA contains a five nucleotide sequence located between the 
second and seventh nucleotide in the 22-23nt miRNA (Valencia-Sanchez et al., 2006).  This is 
called a “seed sequence.”  This region is thought to be specifically important for most, if not all, 
miRNA because this location has been highly conserved though evolution.  The end, or 3’ 
region, of the miRNA is associated with the destabilizing and degrading of the target mRNA.  
There are specific sites in this region that act as cleavage sites, for example, the 10th and 11th 
nucleotide region that acts as a marker for endonuclease activity.  When mi-RNA is properly 
base paired with the target mRNA, the cutting and degrading activity of this class of enzymes is 
directed toward the middle of the polynucleotide chain. The cleavage of the mRNA greatly 
destabilized and can start a cascade of nuclease activity resulting in decreased gene expression 
due to reduced mRNA translation into proteins. (Valencia-Sanchez et al., 2006).    
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Nucleases are a family of enzymes that cut and degrade nucleotide regions. In this case 
the endonuclease activity is directed toward the 3’UTR bound to miRNA. In order for this 
activity to occur, the base pairs between the miRNA and the mRNA need to be perfect.  There 
are few exceptions. The cleavage activity also needs to be mediated by Ago2.  Ago2 is the only 
Ago in its family that is able to mediate this cleavage activity. 
 Processing Bodies (P-Bodies):  Similar to site-specific cleavage, mRNAs may be 
degraded by cellular organelles known as Processing bodies (P-bodies). P-bodies are cellular 
organelles that contain nucleases capable of degrading “unwanted” nucleotide sequences.  
MicroRNAs mediate the movement of mRNAs to these organelles. Gene expression is affected 
by microRNA function because transported mRNAs can be degraded in the P-Bodies, but are 
also simply just sequestered away from translational machinery. The ability of microRNA to 
alter gene expression is dynamic because the rate and impact of its regulation is largely 
dependent on the target and its importance in the cell. Therefore, it is important to look at the 
whole picture, not just the specifics of how the P-bodies degrade the nucleotides.  The rate of 
translation is affected by the rate of entry and exit into the P-bodies because those mRNA are no 
longer viable for translation. Therefore, mechanisms that control the rate of mRNA entry into P-
Bodies, such as miRNAs, are a critical component of the equation.   
 Translation Inhibition via RISC: MicroRNAs can directly inhibit translation of its 
target mRNA. The RISC complex has been shown to inhibit initiation factors needed for the start 
of translation (Valencia-Sanchez et al., 2006).  Additionally, RISC can alter the course of mRNA 
fate.  Options for free mRNA in the cytoplasm are 1) translation, 2) cleavage, or 3) degradation 
by P-bodies. Kinetics dictates which outcome option is implemented (Valencia-Sanchez et al., 
2006).  If the concentration of P-body associated RNA binding proteins (mRNPs) is greater than 
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translational machinery, the mRNA is more likely to be sent to the P-body.  RISC is essential in 
this role because it helps mRNPs assemble while blocking initiation factors.  Thus, the RISC 
complex is tilting equilibrium in the favor of reduced gene expression (Valencia-Sanchez et al., 
2006).  
 Adenine/Uracil Regulatory Sequence (ARE): The last mechanism is a slicer 
independent pathway for mRNA decay.  When other Ago proteins 1,3,or 4 assemble with 
miRNA and RISC, rather than Ago-2, the complex does not have the slicing activity that Ago2 
associated complexes do. Rather, the high decay rate of mRNA has been correlated to an AU-
rich (Adenine adenine and Uracileuracile) 3’ UTR regulatory sequence (ARE) (Valencia-
Sanchez et al., 2006).  ARE’s play a role in controlling the decay rate of mRNA.  This ultimately 
alters the rate at which translation and protein production occur. Therefore, they play a role in 
reducing the amount of mRNA to be translated and thus reducing gene expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
